These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28255998)

  • 1. A novel broth medium for enhanced growth of Francisella tularensis.
    Morris BJ; Buse HY; Adcock NJ; Rice EW
    Lett Appl Microbiol; 2017 Jun; 64(6):394-400. PubMed ID: 28255998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel brain heart infusion broth supports the study of common Francisella tularensis serotypes.
    Mc Gann P; Rozak DA; Nikolich MP; Bowden RA; Lindler LE; Wolcott MJ; Lathigra R
    J Microbiol Methods; 2010 Feb; 80(2):164-71. PubMed ID: 20005265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of viable Francisella tularensis in environmental matrices by culture-based PCR.
    Buse HY; Morris BJ; Rice EW
    BMC Microbiol; 2020 Mar; 20(1):66. PubMed ID: 32213160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid viability polymerase chain reaction method for detection of Francisella tularensis.
    Kane SR; Shah SR; Alfaro TM
    J Microbiol Methods; 2019 Nov; 166():105738. PubMed ID: 31626892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Francisella tularensis ΔpdpC as a candidate live attenuated vaccine against respiratory challenge by a virulent SCHU P9 strain of Francisella tularensis in a C57BL/6J mouse model.
    Tian D; Uda A; Park ES; Hotta A; Fujita O; Yamada A; Hirayama K; Hotta K; Koyama Y; Azaki M; Morikawa S
    Microbiol Immunol; 2018 Jan; 62(1):24-33. PubMed ID: 29171073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against Francisella tularensis--past, present and future.
    Conlan JW
    Expert Rev Vaccines; 2004 Jun; 3(3):307-14. PubMed ID: 15176947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain.
    Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J
    Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Francisella tularensis as a potential agent of bioterrorism?
    Maurin M
    Expert Rev Anti Infect Ther; 2015 Feb; 13(2):141-4. PubMed ID: 25413334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth conditions and environmental factors impact aerosolization but not virulence of Francisella tularensis infection in mice.
    Faith SA; Smith LP; Swatland AS; Reed DS
    Front Cell Infect Microbiol; 2012; 2():126. PubMed ID: 23087911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.
    Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL
    Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of a mechanism of oxidative stress regulation in Francisella tularensis live vaccine strain.
    Ma Z; Russo VC; Rabadi SM; Jen Y; Catlett SV; Bakshi CS; Malik M
    Mol Microbiol; 2016 Sep; 101(5):856-78. PubMed ID: 27205902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.
    Hazlett KR; Caldon SD; McArthur DG; Cirillo KA; Kirimanjeswara GS; Magguilli ML; Malik M; Shah A; Broderick S; Golovliov I; Metzger DW; Rajan K; Sellati TJ; Loegering DJ
    Infect Immun; 2008 Oct; 76(10):4479-88. PubMed ID: 18644878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Substrate Usage and Metabolic Fluxes in
    Chen F; Rydzewski K; Kutzner E; Häuslein I; Schunder E; Wang X; Meighen-Berger K; Grunow R; Eisenreich W; Heuner K
    Front Cell Infect Microbiol; 2017; 7():275. PubMed ID: 28680859
    [No Abstract]   [Full Text] [Related]  

  • 20. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.